Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
February 17, 2015
Patent Application Number
13577616
Date Filed
February 8, 2011
Patent Citations Received
Patent Primary Examiner
Patent abstract
Disclosed herein are antisense compounds and methods for selectively of reducing expression of an allelic variant of a gene containing a single nucleotide polymorphism (SNP). Such methods, compounds, and composition are useful to treat, prevent, or ameliorate diseases, including neurodegenerative, such as Huntington's Disease (HD).
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.